The global protein chip market size was worth USD 2.01 billion in 2020 and is estimated to be growing at a CAGR of 18.21% to reach USD 4.64 billion by 2025.
A protein chip is an advanced and high-performance method to detect protein, investigate protein functions, and monitor their expressions. Protein Chip is a technique for monitoring protein activity. In a single experiment, this technique is used to monitor protein expression and determine the function of many proteins. A surface such as nitrocellulose membrane, microtitre plate, glass slip, and bead makes up a protein chip. This surface assists in the monitoring of all protein activities. Protein chips are also known as Protein Microarray. These protein chips are low-cost, automated, quick, and responsive and can track small amounts of reagents or samples. Antibody characterization, protein function analysis, proteomics, and diagnostics are all examples of protein chip applications. In proteomics, DNA microarray was unable to track gene expression levels. Many common methods, such as chromatography and DNA microarray, can be replaced with a protein chip. Large-scale functional chips, analytical capture arrays, and lysate are currently available in the three types of protein chips. Diagnostics, proteomics, protein functional analysis, and antibody characterization are just a few of the areas where protein arrays are used.
The growing need for personalized medicines is one of the significant factors hiking the growth rate of the global protein chip market.
The massive investments in research and development of these methods have further contributed to the market growth. Another factor positively affecting the market is the rising incidences of cancer around the world. The popularity of advanced diagnostic testing has also led to advancements in the protein chip market. The growing quality of healthcare facilities and rising diseases will help the market grow and cater to a considerable population.
Additionally, factors such as the growing rate of cancer incidences, the practice for advanced technology in diagnostic tests, and rising knowledge about personalized medicines are propelling the protein chip market growth. Increasing government initiatives and massive investments in the research and development of these methods contribute to the market's growth. Protein chips are also used to understand the fundamental biology of different organisms based on gene expression, with sales of $731 million in 2016 and expected to expand to $2,024 million by 2023 in the United States. Besides that, developed countries with sophisticated healthcare equipment and facilities, such as the United States, Canada, and others, are expected to catalyze the demand of the protein chip market over the forecast period.
The major restraint for the protein chip market is the production of high throughput protein. It is a scientific experimentation technique that involves screening big compound libraries for activity against biological objectives via automation. Maintaining the quality of proteins is another factor because their quality will determine the quality of resultant protein microarrays. Making people and nations more aware of this technique and its benefits is also a hurdle right now.
The technology of protein chips is advancing rapidly, resulting in better economies in some areas, such as Asia. This factor is expected to open up numerous opportunities for market growth. Protein chips produce array patterns converted into proteomic maps or fingerprints that show the proteome's detailed composition. In the coming years, protein expression profiling, biomarker discovery, and disease diagnostics will be prioritized. These methodologies are expected to have a huge effect on biomedicine, biotechnology, and high-throughput proteomics research.
The global protein chip market presents numerous challenges in various critical areas, especially in terms of producing proteins in a high-throughput manner. It's a scientific experimentation approach that involves automating the screening for activity against biological targets. Besides that, protein quality must be considered since it will decide the quality of the resulting protein microarrays. Despite significant investments by many firms, proteins are scarce on the market. Changes in the microenvironment have a major impact on proteins. Maintaining protein arrays in a stable state for long periods of time is a challenge for the market players. Low yield production of consistent and reliable proteins can stifle market growth in the future.
Impact of COVID-19 on the global protein chip market:
COVID-19 has positively impacted the protein chip market. The corona virus-infected patients require many tests to be conducted to find out the body's vitals. Since there is no vaccine right now, the market is expected to grow at a much faster rate. The protein chip helps identify proteins and how the virus infects them, giving us an overall body check-up. The government is assisting countries that have the presence of advanced biotech companies. This help from governments has increased the market growth rate.
Market Size Available
2019 to 2025
2020 to 2025
By Technology, Application, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
Market Leaders Profiled
SEQUENOM, Inc., Sigma Aldrich Corporation, Affymetrix, Inc., EMD Millipore, Illumina, Inc., Life Technologies Corporation, and Agilent Technologies.
This research report on the global protein chip market has been segmented and sub-segmented based on the technology, application, and region.
Protein Chip Market – By Technology:
Based on technology, the Functional protein microarray segment accounts for a significant share in the market due to its widespread application in advanced diagnostics.
The functional protein microarray held the largest market share in 2019 and is expected to grow with a healthy growth rate in the future. The application of functional protein microarray, in particular, has flourished in studying protein function and the construction of networks and pathways. Further research and development fully unlock the technology’s potential.
Analytical microarray is expected to grow at a reasonable rate in the future. The key features of analytical microarray include high throughput and relatively low costs due to minimal reagent consumption. Other features are multiplexing, fast kinetics, and hence measurements, and the possibility of functional integration. The increased funding for research and development in this technology will help us exploit the full benefits of protein microarray in the future.
Protein Chip Market – By Application:
Based on the application, the Proteomics segment is the largest revenue-generating segment.
Proteomics had the largest share in revenue in 2019. Proteomics is used in biomedical research and drug discovery studies based on conduction chips, and due to this factor, the growth is expected to be healthy in the future. It has half the market share in the overall protein chip market. Its broad spectrum of applications such as Spectroscopy, X-ray Crystallography, and Chromatography. Other proteomics applications are Supercritical Fluid Chromatography, Electrophoresis, SPR (Surface Plasmon Resonance) Systems, and Protein Fractionation System.
Diagnostics using protein chips are expected to grow with a promising growth rate in the future. The prevalence of COVID 19 has increased the market growth and, thus, increasing the market growth of protein chips. Monoclonal and recombinant antibodies provide a never-ending source of molecules and can produce endless possibilities for novel genetic constructs.
The protein function analysis sub-segment is expected to grow at a reasonable rate in the future. Protein chips are used to assign roles to the proteins, and thus with the development of technology, we can see revolutionary applications of protein chips in this segment.
Protein Chip Market – By Region:
Geographically, the Global Protein Chip market was dominated by North America, followed by Europe in 2019. The Asia Pacific is expected to grow at a significant rate during the forecast period.
North America is expected to lead the market among all other regions during the forecast period. The development of healthcare facilities due to government initiatives and allotment of more funding has helped this market's growth. Market players in the biotechnology field and their collaborations to use the technology for different applications will propel the protein chips market growth.
The European region is expected to grow at a prominent rate and captured the second-largest market in 2019. The development of quality healthcare and the rise in cancer cases due to the increasing population has driven market growth. The governments are now taking more interest in this method due to its wide applications. Thus, initiatives from the government will boost the confidence of research centers in the region.
The Asia Pacific is expected to grow with the highest rate among all other regions in the future. The rise in population in countries like India and China is the primary reason contributing to the growth. The rising cases of diseases requiring diagnosis in the region will drive the development of the market.
KEY MARKET PARTICIPANTS:
Notable companies leading the global protein chip market profiled in this report are SEQUENOM, Inc., Sigma Aldrich Corporation, Affymetrix, Inc., EMD Millipore, Illumina, Inc., Life Technologies Corporation, and Agilent Technologies.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Analytical microarrays
5.1.3 Functional protein microarrays
5.1.4 Reverse phase protein microarray
5.1.5 Y-o-Y Growth Analysis, By technology
5.1.6 Market Attractiveness Analysis, By technology
5.1.7 Market Share Analysis, By technology
5.2.4 Protein functional analysis
5.2.5 Antibody characterization
5.2.6 Y-o-Y Growth Analysis, By application
5.2.7 Market Attractiveness Analysis, By application
5.2.8 Market Share Analysis, By application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By technology
184.108.40.206 By application
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By technology
22.214.171.124 By application
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By technology
184.108.40.206 By application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Agilent Technologies
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Affymetrix Inc.
8.3 Sigma Aldrich Corporation
8.5 Life Technologies Corporation
8.6 IIIumina Inc.
8.7 EMD Milipore
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures